Terms: = Germ cell tumor AND HER1, YOR227W
23 results:
1. RNA Aptamers for Theranostics of Glioblastoma of Human Brain.
Kopylov AM; Fab LV; Antipova O; Savchenko EA; Revishchin AV; Parshina VV; Pavlova SV; Kireev II; Golovin AV; Usachev DY; Pavlova GV
Biochemistry (Mosc); 2021 Aug; 86(8):1012-1024. PubMed ID: 34488577
[TBL] [Abstract] [Full Text] [Related]
2. Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer.
Maisel SA; Broka D; Atwell B; Bunch T; Kupp R; Singh SK; Mehta S; Schroeder J
J Transl Med; 2019 Jun; 17(1):201. PubMed ID: 31215437
[TBL] [Abstract] [Full Text] [Related]
3. Dacomitinib: an investigational drug for the treatment of glioblastoma.
Sepúlveda JM; Sánchez-Gómez P; Vaz Salgado MÁ; Gargini R; Balañá C
Expert Opin Investig Drugs; 2018 Oct; 27(10):823-829. PubMed ID: 30247945
[TBL] [Abstract] [Full Text] [Related]
4. Simultaneous Interference with her1/EGFR and RAC1 Signaling Drives Cytostasis and Suppression of Survivin in Human Glioma cells in Vitro.
Karpel-Massler G; Westhoff MA; Kast RE; Dwucet A; Karpel-Massler S; Nonnenmacher L; Siegelin MD; Wirtz CR; Debatin KM; Halatsch ME
Neurochem Res; 2017 May; 42(5):1543-1554. PubMed ID: 28271323
[TBL] [Abstract] [Full Text] [Related]
5. Targeting of EGFR and HER2 with therapeutic antibodies and siRNA: a comparative study in glioblastoma cells.
Wichmann H; Güttler A; Bache M; Taubert H; Rot S; Kessler J; Eckert AW; Kappler M; Vordermark D
Strahlenther Onkol; 2015 Feb; 191(2):180-91. PubMed ID: 25159136
[TBL] [Abstract] [Full Text] [Related]
6. Combined inhibition of her1/EGFR and RAC1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells.
Karpel-Massler G; Westhoff MA; Zhou S; Nonnenmacher L; Dwucet A; Kast RE; Bachem MG; Wirtz CR; Debatin KM; Halatsch ME
Mol Cancer Ther; 2013 Sep; 12(9):1783-95. PubMed ID: 23832120
[TBL] [Abstract] [Full Text] [Related]
7. Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.
Phuphanich S; Wheeler CJ; Rudnick JD; Mazer M; Wang H; Nuño MA; Richardson JE; Fan X; Ji J; Chu RM; Bender JG; Hawkins ES; Patil CG; Black KL; Yu JS
Cancer Immunol Immunother; 2013 Jan; 62(1):125-35. PubMed ID: 22847020
[TBL] [Abstract] [Full Text] [Related]
8. Targeting ErbB receptors in high-grade glioma.
Berezowska S; Schlegel J
Curr Pharm Des; 2011; 17(23):2468-87. PubMed ID: 21827413
[TBL] [Abstract] [Full Text] [Related]
9. Vandetanib: first global approval.
Commander H; Whiteside G; Perry C
Drugs; 2011 Jul; 71(10):1355-65. PubMed ID: 21770481
[TBL] [Abstract] [Full Text] [Related]
10. Erlotinib in glioblastoma: lost in translation?
Karpel-Massler G; Westhoff MA; Kast RE; Wirtz CR; Halatsch ME
Anticancer Agents Med Chem; 2011 Oct; 11(8):748-55. PubMed ID: 21707495
[TBL] [Abstract] [Full Text] [Related]
11. Drug combinations enhancing the antineoplastic effects of erlotinib in high-grade glioma.
Karpel-Massler G; Wirtz CR; Halatsch ME
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):384-94. PubMed ID: 21612575
[TBL] [Abstract] [Full Text] [Related]
12. Expression and significance of HER family receptors in neuroblastic tumors.
Izycka-Swieszewska E; Wozniak A; Drozynska E; Kot J; Grajkowska W; Klepacka T; Perek D; Koltan S; Bien E; Limon J
Clin Exp Metastasis; 2011 Mar; 28(3):271-82. PubMed ID: 21203803
[TBL] [Abstract] [Full Text] [Related]
13. Ribozyme-mediated inhibition of 801-bp deletion-mutant epidermal growth factor receptor mRNA expression in glioblastoma multiforme.
Karpel-Massler G; Wirtz CR; Halatsch ME
Molecules; 2010 Jun; 15(7):4670-8. PubMed ID: 20657384
[TBL] [Abstract] [Full Text] [Related]
14. EGF receptor inhibitors in the treatment of glioblastoma multiform: old clinical allies and newly emerging therapeutic concepts.
Gadji M; Crous AM; Fortin D; Krcek J; Torchia M; Mai S; Drouin R; Klonisch T
Eur J Pharmacol; 2009 Dec; 625(1-3):23-30. PubMed ID: 19836372
[TBL] [Abstract] [Full Text] [Related]
15. Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?
Karpel-Massler G; Schmidt U; Unterberg A; Halatsch ME
Mol Cancer Res; 2009 Jul; 7(7):1000-12. PubMed ID: 19584260
[TBL] [Abstract] [Full Text] [Related]
16. ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839).
Djerf EA; Trinks C; Abdiu A; Thunell LK; Hallbeck AL; Walz TM
Melanoma Res; 2009 Jun; 19(3):156-66. PubMed ID: 19434003
[TBL] [Abstract] [Full Text] [Related]
17. tumor-targeted quantum dots can help surgeons find tumor boundaries.
Arndt-Jovin DJ; Kantelhardt SR; Caarls W; de Vries AH; Giese A; Jovin Ast TM
IEEE Trans Nanobioscience; 2009 Mar; 8(1):65-71. PubMed ID: 19304503
[TBL] [Abstract] [Full Text] [Related]
18. Epidermal growth factor can induce apoptosis in neuroblastoma.
Chiu B; Mirkin B; Madonna MB
J Pediatr Surg; 2007 Mar; 42(3):482-8. PubMed ID: 17336184
[TBL] [Abstract] [Full Text] [Related]
19. Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours.
Halatsch ME; Schmidt U; Behnke-Mursch J; Unterberg A; Wirtz CR
Cancer Treat Rev; 2006 Apr; 32(2):74-89. PubMed ID: 16488082
[TBL] [Abstract] [Full Text] [Related]
20. [EGFR-expression in pulmonary neuroendocrine cell hyperplasia].
Kuhnen C; Winter BU
Pathologe; 2006 Mar; 27(2):147-51. PubMed ID: 16435094
[TBL] [Abstract] [Full Text] [Related]
[Next]